checkAd
    Startseite > Aktien > Alterity Therapeutics > Nachrichten
    Alterity Therapeutics Aktie
    1,9850
     
    EUR
    +10,28 %
    +0,1850 EUR
    Letzter Kurs 12:29:57 Lang & Schwarz
    1,6500
     
    EUR
    4.644 STK
    Geldkurs 12:29:57
    2,3200
     
    EUR
    4.644 STK
    Briefkurs 12:29:57
    ISIN: US02155X2053 · WKN: A3D4GD · Australien

    Neueste Nachrichten

    Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
    08.05.24 · globenewswire · Alterity Therapeutics
    Appendix 4C – Q3 FY24 Quarterly Cash Flow Report
    30.04.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia
    29.04.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
    17.04.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
    10.04.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
    26.03.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
    20.02.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
    06.02.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
    29.01.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
    22.01.24 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Appoints Phillip Hains as Chief Financial Officer
    21.12.23 · globenewswire · Alterity Therapeutics
    Alterity Therapeutics Announces Presentation of Novel Biomarker Data for Evaluation of Multiple System Atrophy
    27.11.23 · globenewswire · Alterity Therapeutics